Warning: Canaglflozin (Invokana) Doubles the Risk of Amputation in T2 Diabetes posted first on https://diabeticmediterraneandiet.com
Wednesday, May 17, 2017
Warning: Canaglflozin (Invokana) Doubles the Risk of Amputation in T2 Diabetes
Yesterday the U.S. Food and Drug Administration ruled that Invokana doubles the risk of foot and leg amputations in type 2 diabetics, compared to treatment with placebo. Invokana is an SGLT2 inhibitor called canagliflozin. There are several other drugs in … Continue reading
Warning: Canaglflozin (Invokana) Doubles the Risk of Amputation in T2 Diabetes posted first on https://diabeticmediterraneandiet.com
Warning: Canaglflozin (Invokana) Doubles the Risk of Amputation in T2 Diabetes posted first on https://diabeticmediterraneandiet.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment